284 related articles for article (PubMed ID: 32315343)
1. Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression.
Yadav VK; Lee TY; Hsu JB; Huang HD; Yang WV; Chang TH
PLoS One; 2020; 15(4):e0231594. PubMed ID: 32315343
[TBL] [Abstract][Full Text] [Related]
2. Metalloproteinases in Endometrial Cancer-Are They Worth Measuring?
Michalczyk K; Cymbaluk-Płoska A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830354
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha activates MAPK signaling pathway to promote the development of endometrial cancer.
Liu A; Zhang D; Yang X; Song Y
J Cell Biochem; 2019 Oct; 120(10):17593-17601. PubMed ID: 31140648
[TBL] [Abstract][Full Text] [Related]
4. The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression.
Chen S; Zong ZH; Wu DD; Sun KX; Liu BL; Zhao Y
Mol Carcinog; 2017 Apr; 56(4):1361-1371. PubMed ID: 27991682
[TBL] [Abstract][Full Text] [Related]
5. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Hum Reprod; 2018 Mar; 33(3):399-410. PubMed ID: 29309596
[TBL] [Abstract][Full Text] [Related]
6. [Expression profile of genes associated with the histaminergic system estimated by oligonucleotide microarray analysis HG-U133A in women with endometrial adenocarcinoma].
Jeda A; Witek A; Janikowska G; Cwynar G; Janikowski T; Ciałon M; Orchel J; Mazurek U
Ginekol Pol; 2014 Mar; 85(3):172-9. PubMed ID: 24783427
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of ARTN and MMP-9 in endometrial carcinoma.
Wang XH; Liu YN; Tian K; Yao CX; Li LM; Zheng YQ; Shi ZM
J Biol Regul Homeost Agents; 2017; 31(4):879-887. PubMed ID: 29254290
[TBL] [Abstract][Full Text] [Related]
8. Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.
Bian Y; Chang X; Liao Y; Wang J; Li Y; Wang K; Wan X
Oncol Rep; 2016 Aug; 36(2):803-10. PubMed ID: 27373314
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and metastasis.
Wu AY; Hu Y; Cang W; Li D; Wang WJ; Tian Q; Gu LY; Zhang N; Ji F; Qiu LH
Exp Cell Res; 2019 Sep; 382(2):111468. PubMed ID: 31201812
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics analysis of key differentially expressed genes in well and poorly differentiated endometrial carcinoma.
Zang Y; Dong M; Zhang K; Tian W; Wang Y; Xue F
Mol Med Rep; 2018 Jul; 18(1):467-476. PubMed ID: 29749513
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
12. Analysis of carcinogenic signaling networks in endometrial cancer identifies RAB17 as a potential target.
Zhou X; Xia G; Liu Y; Xin X; Shi R; An L; Zhang J; Zhao R; Zhao Y; Wang H
J Cell Physiol; 2021 Jan; 236(1):328-339. PubMed ID: 32529729
[TBL] [Abstract][Full Text] [Related]
13. Meta-dimensional data integration identifies critical pathways for susceptibility, tumorigenesis and progression of endometrial cancer.
Wei R; De Vivo I; Huang S; Zhu X; Risch H; Moore JH; Yu H; Garmire LX
Oncotarget; 2016 Aug; 7(34):55249-55263. PubMed ID: 27409342
[TBL] [Abstract][Full Text] [Related]
14. Urokinase-type plasminogen activator resulting from endometrial carcinogenesis enhances tumor invasion and correlates with poor outcome of endometrial carcinoma patients.
Huang CY; Chang MC; Huang WY; Huang CT; Tang YC; Huang HD; Kuo KT; Chen CA; Cheng WF
Sci Rep; 2015 Jun; 5():10680. PubMed ID: 26033187
[TBL] [Abstract][Full Text] [Related]
15. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.
Wang Q; Xu K; Tong Y; Dai X; Xu T; He D; Ying J
J Cell Mol Med; 2020 Apr; 24(8):4533-4546. PubMed ID: 32150330
[TBL] [Abstract][Full Text] [Related]
16. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
[TBL] [Abstract][Full Text] [Related]
17. Telomere and Telomerase-Associated Proteins in Endometrial Carcinogenesis and Cancer-Associated Survival.
Button L; Rogers B; Thomas E; Bradfield A; Alnafakh R; Drury J; Hapangama DK
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054812
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.
Altadill T; Dowdy TM; Gill K; Reques A; Menon SS; Moiola CP; Lopez-Gil C; Coll E; Matias-Guiu X; Cabrera S; Garcia A; Reventos J; Byers SW; Gil-Moreno A; Cheema AK; Colas E
Sci Rep; 2017 Aug; 7(1):8803. PubMed ID: 28821813
[TBL] [Abstract][Full Text] [Related]
19. A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix.
Yu C; You M; Zhang P; Zhang S; Yin Y; Zhang X
Cancer Med; 2021 Jul; 10(13):4629-4643. PubMed ID: 34121340
[TBL] [Abstract][Full Text] [Related]
20. Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis.
Li Y; Zhang Z
Sci Rep; 2014 Nov; 4():7097. PubMed ID: 25403569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
